Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, biomarkers, and other cancer treatments, will be highlighted at the American ...
HER2-positive (HER2+) breast cancer treatments come with a range of unpleasant side effects. However, there are strategies ...
At the European Society for Medical Oncology (ESMO) 2024, renowned experts, Michael Jewett, Andrea Necchi and Laurence Albiges discuss ...